Results 241 to 250 of about 278,336 (309)

Immune checkpoint inhibitor-based combinatory and alternative strategies for immune treatment of lung cancers. [PDF]

Front Immunol
Park JY, Kwak CH, Chang YC, Kim CH.
europepmc   +1 more source

Mechanistic Learning for Predicting Survival Outcomes in Head and Neck Squamous Cell Carcinoma

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 540-550, March 2025.
ABSTRACT We employed a mechanistic learning approach, integrating on‐treatment tumor kinetics (TK) modeling with various machine learning (ML) models to address the challenge of predicting post‐progression survival (PPS)—the duration from the time of documented disease progression to death—and overall survival (OS) in Head and Neck Squamous Cell ...
Kevin Atsou, Anne Auperin, Jôel Guigay, Sébastien Salas, Sebastien Benzekry   +4 more
wiley   +1 more source

RFC5 and STAT3 form a transcriptional complex to drive NSCLC progression via c-Myc. [PDF]

iScience
Yan J, Yi T, Tian W, Wu J, Yu R, Zhang S, Cheng Z, Di X, Jiang H, Wen D, Zhang S.   +10 more
europepmc   +1 more source

Melittin Reprograms Tumor‐Associated Macrophages Through CD18‐Mediated Immunomodulation

Phytotherapy Research, EarlyView.
Melittin selectively targets CD18 to deplete M2‐TAMs and remodel the TME to suppress tumor growth. ABSTRACT Tumor‐associated macrophages (TAMs), particularly the M2‐like subtype, contribute to an immunosuppressive tumor microenvironment and promote tumor progression.
Ik‐Hwan Han, Hyunju Lee, Eunbin Ko, Ilseob Choi, Soyoung Kim, Deok‐Sang Hwang, Hyunsu Bae   +6 more
wiley   +1 more source

Exploring the landscape of programmed cell death protein-1 and cluster of differentiation 28 positive T cells and cytokines in non-small cell lung cancer: A retrospective case-control study. [PDF]

J Int Med Res
Yang Y, Li RC, Lyu C, Zhang W, Sun Y, Xie R.   +5 more
europepmc   +1 more source

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

Phytotherapy Research, EarlyView.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko, Victoriya Georgiyants, Liudas Ivanauskas, Olha Mykhailenko   +3 more
wiley   +1 more source

LncRNA <i>RAMS11</i>-dependent <i>NOTCH3</i> activation drives tumor progression in non-small cell lung cancer. [PDF]

NAR Cancer
Jeffers GG, Kim Y, White NM, Lin L, Rozycki EB, Ly A, Maher CA.   +6 more
europepmc   +1 more source

Harmonizing biomarker testing in NSCLC: The critical role of cytopathology in delivering comprehensive biomarker testing for patients with NSCLC. [PDF]

Cancer Cytopathol
Roy-Chowdhuri S, Mani H.
europepmc   +1 more source

Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts. [PDF]

Cancer Res Commun
Pilco-Janeta DF, De la Cruz-Puebla M, Guamán-Pilco DR, Montenegro D, Miranda W.   +4 more
europepmc   +1 more source

Increased reporting of interstitial pneumonitis with combined EGFR-TKI and PD-1/PD-L1 inhibitor therapy in NSCLC: a pharmacovigilance analysis of 67,818 reports. [PDF]

Front Immunol
Tao J, Fu Z.
europepmc   +1 more source